X hits on this document

39 views

0 shares

0 downloads

0 comments

7 / 12

4.118-X§4.118—Schedule of ratings–skin      4.118-X

Note: If a skin malignancy requires therapy that is comparable to that used for

systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more

extensive than to the skin, or surgery more extensive than wide local excision,

a 100-percent evaluation will be assigned from the date of onset of treatment,

and will continue, with a mandatory VA examination six months following

the completion of such antineoplastic treatment, and any change in evaluation

based upon that or any subsequent examination will be subject to the

provisions of §3.105(e) of this chapter. If there has been no local recurrence

or metastasis, evaluation will then be made on residuals. If treatment is

confined to the skin, the provisions for a 100-percent evaluation do not

apply.

7819  Benign skin neoplasms:  

Rate as disfigurement of the head, face, or neck (DC 7800), scars (DC’s 7801, 7802,

7803, 7804, or 7805), or impairment of function.

7820  Infections of the skin not listed elsewhere (including bacterial, fungal, viral,

treponemal and parasitic diseases):  

Rate as disfigurement of the head, face, or neck (DC 7800), scars (DC’s 7801, 7802,

7803, 7804, or 7805), or dermatitis (DC 7806), depending upon the predominant

disability.

7821  Cutaneous manifestations of collagen-vascular diseases not listed elsewhere

(including scleroderma, calcinosis cutis, and dermatomyositis):

More than 40 percent of the entire body or more than 40 percent of

exposed areas affected, or; constant or near-constant systemic therapy

such as corticosteroids or other immunosuppressive drugs required

during the past 12-month period60

20 to 40 percent of the entire body or 20 to 40 percent of exposed

areas affected, or; systemic therapy such as corticosteroids or

other immunosuppressive drugs required for a total duration of six

weeks or more, but not constantly, during the past 12-month period30

At least 5 percent, but less than 20 percent, of the entire body, or at

least 5 percent, but less than 20 percent, of exposed areas affected,

or; intermittent systemic therapy such as corticosteroids or other

immunosuppressive drugs required for a total duration of less than

six weeks during the past 12-month period10

Less than 5 percent of the entire body or exposed areas affected, and;

no more than topical therapy required during the past 12-month

period0

Or rate as disfigurement of the head, face, or neck (DC 7800) or scars (DC’s

7801, 7802, 7803, 7804, or 7805), depending upon the predominant

(No. 51  2/5/12)

Document info
Document views39
Page views39
Page last viewedWed Dec 07 19:41:49 UTC 2016
Pages12
Paragraphs368
Words3750

Comments